HIGHLIGHTS
- who: Alexander Ru00f6th from the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany have published the paper: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study, in the Journal: (JOURNAL)
- what: The aim of this study was to analyse further the PROs from the pivotal CARDINAL study in patients with CAD and a recent history of transfusion. The aim in part A was to assess if treatment with sutimlimab could increase haemoglobin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.